Acadia Healthcare (NASDAQ:ACHC) Research Coverage Started at KeyCorp

KeyCorp assumed coverage on shares of Acadia Healthcare (NASDAQ:ACHC) in a research note published on Friday, Marketbeat.com reports. The firm issued a sector weight rating on the stock. KeyCorp also issued estimates for Acadia Healthcare’s FY2024 earnings at $3.51 EPS, FY2025 earnings at $3.86 EPS and FY2026 earnings at $4.47 EPS.

Other research analysts have also recently issued reports about the company. Royal Bank of Canada reaffirmed an outperform rating and set a $94.00 price objective on shares of Acadia Healthcare in a research report on Friday, September 20th. Cantor Fitzgerald reissued a neutral rating and issued a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, October 1st. Barclays lowered their price target on Acadia Healthcare from $83.00 to $76.00 and set an overweight rating on the stock in a report on Monday, September 30th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on Acadia Healthcare from $70.00 to $75.00 and gave the stock a hold rating in a report on Friday, August 2nd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of Hold and an average target price of $86.67.

Acadia Healthcare Price Performance

NASDAQ ACHC opened at $54.82 on Friday. Acadia Healthcare has a one year low of $53.22 and a one year high of $87.77. The stock has a 50-day moving average of $72.20 and a 200 day moving average of $70.19. The company has a market capitalization of $5.09 billion, a price-to-earnings ratio of -391.57, a PEG ratio of 1.57 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.18.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.04. The business had revenue of $796.00 million for the quarter, compared to analysts’ expectations of $784.38 million. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The business’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same period last year, the firm posted $0.92 earnings per share. On average, sell-side analysts forecast that Acadia Healthcare will post 3.51 EPS for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Hedge funds have recently made changes to their positions in the stock. Blue Trust Inc. boosted its position in Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after purchasing an additional 248 shares in the last quarter. GAMMA Investing LLC increased its stake in Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after acquiring an additional 241 shares during the last quarter. Mather Group LLC. acquired a new stake in Acadia Healthcare during the first quarter worth $48,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Acadia Healthcare in the second quarter valued at $59,000. Finally, nVerses Capital LLC acquired a new stake in shares of Acadia Healthcare in the second quarter valued at $95,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.